Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia

Non-cancerous complications in HTLV-1 carriers

Expert Rev Anti Infect Ther. 2024 Mar 27. doi: 10.1080/14787210.2024.2336547. Online ahead of print. ABSTRACT INTRODUCTION: Human T-cell leukemia virus type 1 (HTLV-1) carriers may develop adult T-cell leukemia (ATL), or HTLV-1-associated myelopathy (HAM)/tropical...